The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme
Authors:
- 22 June 2020
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 59 (9) , 1064-1075
Abstract
The aggressive nature of glioblastoma multiforme (GBM) may be attributed to the dysregulation of pathways driving both proliferation and invasion. EphrinB2, a membrane‐bound ligand for some of the Eph receptors, has emerged as a critical target regulating these pathways. In this study, we investigated the role of ephrinB2 in regulating proliferation and invasion in GBM using intracranial and subcutaneous xenograft models. The Cancer Genome Atlas analysis suggested high transcript and low methylation levels of ephrinB2 as poor prognostic indicators in GBM, consistent with its role as an oncogene. EphrinB2 knockdown, however, increased tumor growth, an effect that was reversed by ephrinB2 Fc protein. This was associated with EphB4 receptor activation, consistent with the data showing a significant decrease in tumor growth with ephrinB2 overexpression. Mechanistic analyses showed that ephrinB2 knockdown has anti‐invasive but pro‐proliferative effects in GBM. EphB4 stimulation following ephrinB2 Fc treatment in ephrinB2 knockdown tumors was shown to impart strong anti‐proliferative and anti‐invasive effects, which correlated with decrease in PCNA, p‐ERK, vimentin, Snail, Fak, and increase in the E‐cadherin levels. Overall, our study suggests that ephrinB2 cannot be used as a sole therapeutic target. Concomitant inhibition of ephrinB2 signaling with EphB4 activation is required to achieve maximal therapeutic benefit in GBM.Keywords
Funding Information
- National Institute of Dental and Craniofacial Research (R01 DE028282‐01, R01 DE028529‐01)
This publication has 48 references indexed in Scilit:
- Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growthBlood, 2012
- Transcriptional co-regulation of neuronal migration and laminar identity in the neocortexDevelopment, 2012
- Activation of Glial FGFRs Is Essential in Glial Migration, Proliferation, and Survival and in Glia-Neuron Signaling during Olfactory System DevelopmentPLOS ONE, 2012
- EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinaseOncogene, 2012
- Aberrant Signaling Pathways in GliomaCancers, 2011
- Eph receptors and ephrins in cancer: bidirectional signalling and beyondNature Reviews Cancer, 2010
- The phosphorylation of ephrin‐B2 ligand promotes glioma cell migration and invasionInternational Journal of Cancer, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- EphB2 and EphB4 receptors forward signaling promotes SDF-1–induced endothelial cell chemotaxis and branching remodelingBlood, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005